Antibiotic use is associated with SJ syndrome and toxic epidermal necrosis, with sulfonamides being the most common culprits.

Published Date: 17 Feb 2023

Antibiotic use linked to SJ syndrome and toxic epidermal necrosis, sulfonamides are worst culprits in new study...

Read Full News

Latest News

Upadacitinib Effective in PsA After TNF Inhibitor Failure

Upadacitinib is linked to effective clinical responses in patients with psoriatic arthritis who have received prior TNF inhibitor therapy.

Does Tapering TNF Inhibitors Maintain Low Disease Activity?

In patients with psoriatic arthritis and axial spondyloarthritis, a treat-to-target tapering strategy for TNF inhibitors may maintain low disease activity for up to 2 years.

FDA Approves First Oral Drug for Dermatomyositis in Adults

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune disease, in adults.

Early Step-Down Safe, Cost-Effective in Stable Candidiasis

Switching from an echinocandin to an azole within 5 days is not associated with worse outcomes in clinically stable adults with invasive candidiasis, a study shows.

How Safe Is Lifileucel After Patients Go Home?

The T-cell therapy’s inpatient toxicity is well-characterized, but the risks patients may face after hospital discharge have been unclear.

China Approves J&J Psoriasis Pill Icotyde, Says Drugmaker

China's drug regulator has approved Johnson & Johnson's oral pill ⁠for psoriasis, the company said on Thursday, intensifying competition in the ⁠world's second-largest...

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Latest News

Upadacitinib is linked to effective clinical responses in patients with psoriatic arthritis who have received prior TNF inhibitor therapy.

In patients with psoriatic arthritis and axial spondyloarthritis, a treat-to-target tapering strategy for TNF inhibitors may maintain low disease activity for up to 2 years.

The FDA has approved brepocitinib (Lisraya), an oral JAK inhibitor, for the treatment of dermatomyositis, a rare autoimmune disease, in adults.

Switching from an echinocandin to an azole within 5 days is not associated with worse outcomes in clinically stable adults with invasive candidiasis, a study shows.

The T-cell therapy’s inpatient toxicity is well-characterized, but the risks patients may face after hospital discharge have been unclear.

China's drug regulator has approved Johnson & Johnson's oral pill ⁠for psoriasis, the company said on Thursday, intensifying competition in the ⁠world's second-largest...

News All Time

Guidelines Help Spot Dermatomyositis Patients at High Risk for Cancer

IMACS guidelines are clinically useful for identifying high-risk populations, researchers say

Antihistamines Panned for Eczema

Network meta-analysis finds no meaningful benefit across the board and some harms

FDA Staff Unconvinced Drug for Melanoma Shows Benefit

Replimune's RP1 faces tough test at upcoming FDA advisory panel meeting

Fauci's Diaries Released; Cold Brew Recalled; Carly Simon's Diagnosis

Health news and commentary gathered by MedPage Today staff

What Is the 'Barbie Peptide' and Why Is It Risky?

Dermatologists weigh in on the injectable trend

Twice-Rejected Melanoma Drug Gets Love From FDA Panel

Vote at odds with FDA reviewers

Make the Diagnosis: She’s Losing Her Scalp and Eyebrow Hair. Why?

A 51-year-old woman visited her doctor for asymptomatic hair loss on her scalp and eyebrows that she first noticed approximately 5 months prior. Can you diagnose the patient?

FDA Finally OKs Twice-Rejected Melanoma Drug

Approved in combination with nivolumab for patients who progress on prior anti-PD-1 therapy

'Carrot Maxxing' Is a New Name for an Old Trend

Eating lots of carrots can change the color of the skin, but satisfaction may vary

Tanning Is Getting Hot Again. Here's What It Really Does to Your Skin.

Tanning misinformation abounds online

Pebbled Skin and Excessive Hair Growth on a 5-Year-Old's Back

Just two of the multiple symptoms that began to emerge shortly after birth

Can 'Ferritin Face' Signal Underlying Anemia? Hematologists Weigh In

Patients attribute dull skin, brittle hair, and dark under-eye circles to ferritin deficiency

JAK Inhibitor Might Be the Most Effective One Yet for Severe Alopecia

Trials suggest more hair growth with upadacitinib in teens and adults than previously seen

Flight Attendants, Pilots Have Highest Risk of Dying From Radiation-Linked Cancers

Radiation exposure is greater for people flying at high altitudes

4 Deaths Linked to Medical Device; New FDA Chief? Human-Chimp Hybrid Attempt

Health news and commentary gathered by MedPage Today staff

How Much of a Cancer Drug Is Too Much? Some Are Challenging FDA-Approved Dosages.

— Smaller doses of some drugs could save billions and prevent some of the worst side effects

Recommended News For You

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

According to a study, taking part in a clinical trial for cancer may not actually increase survival.

Combination therapy improves outcomes for advanced triple-negative breast cancer

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

The FDA Approves the New Frontline Aggressive ALL Regimen.

New clinical recommendation for local treatment of oligometastatic lung cancer.

A large study found that monolayers were superior in detecting cancer.

Recommended Articles For You

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors 

Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine 

Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange 

Exploring Innovative Approaches to Esophageal Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pivotal Studies in Double-Expressor DLBCL Yield Divergent Results

2.

FDA Approves ctDNA-Guided Atezolizumab for Bladder Cancer

3.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

4.

AI-based liquid biopsy shows promise for detecting brain cancer

5.

The Kansas Cancer Center awarded two Indian American doctors professorships.

1.

Clinical Guidelines for Targeting the Tumor Microenvironment in Solid Cancers

2.

Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies

3.

Examining Serum Osmolality: What It Is And How To Test For It

4.

Evolutionary Bottlenecks in Tumor Progression

5.

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

2.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

3.

Current Scenario of Cancer- The Incidence of Cancer in Men

4.

Thromboprophylaxis In Medical Settings

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot